Alvotech Expands Biosimilar Reach With Lotus Partnership
Reykjavik, Iceland, August 21, 2026 Alvotech, a biotechnology company focused on the development and manufacture of biosimilar medicines, has...
biopharmaceutical manufacturing
Advertisement
SK pharmteco Showcases Global CDMO Manufacturing at CPHI
Rancho Cordova, California, USA, August 21, 2026 SK pharmteco, a global contract development and manufacturing organization (CDMO), has announced...
Genprex Advances Diabetes Gene Therapy Manufacturing Scale-Up
AUSTIN, Texas, August 18, 2026 Genprex, Inc. has entered into a development and manufacturing agreement with a leading U.S.-based...
NueCell Bio Launches GMP Cell Therapy Development Platform
San Diego, California, August 5, 2026 NueCell Bio has officially launched as a specialized cell therapy science and development...
Nova Biomedical Expands Cell Line Development Platform
WALTHAM, Mass., July 24, 2026 Nova Biomedical has announced the acquisition of certain assets of NanoCellect, a recognized developer...
Advertisements
AstraZeneca’s Etcamah Approved for First-Line Breast Cancer
CAMBRIDGE, UK, July 23, 2026 AstraZeneca has secured European Commission approval for Etcamah (camizestrant) in combination with a CDK4/6...
Repligen’s $1.5B BioLife Deal Expands CGT Portfolio
WALTHAM, Mass. & BOTHELL, Wash., July 22, 2026 Repligen Corporation has announced a definitive agreement to acquire BioLife Solutions...
BeOne Medicines Scales Cancer Drug Production in the U.S.
San Carlos, Calif., July 23, 2026 BeOne Medicines announced a $300 million expansion of its flagship Princeton West Innovation...
Samsung Biologics to Acquire PolyPeptide for CHF 1.46B
INCHEON, South Korea, July 20, 2026 Samsung Biologics has announced a landmark all-cash public tender offer to acquire 100%...
Porton Advanced Secures FDA DMF for UC-MSC Cell Bank
CRANBURY, New Jersey / SUZHOU, China | July 9, 2026 Porton Advanced, a leading Advanced Therapy Medicinal Products (ATMP)...
Advertisement
